Gene against bacterial attack unravelled

October 29, 2008

Dutch researcher Joost Wiersinga from AMC Medical Centre in Amsterdam has unravelled a genetic defence mechanism against the lethal bacteria Burkholderia pseudomallei. The research is the next step towards a vaccine against this bacterium suitable for bioweapons.

Humans have an innate defence system against deadly bacteria. However, how the step from gene to anti-bacterial effect occurs in the body is not yet known. To date, B. Pseudomallei, a bacterium suitable for bioweapons, had managed to elude medics. It can remain hidden in the human body for many years without being detected by the immune system. The bacteria can suddenly become activated and spread throughout the body, resulting in the patient dying from blood poisoning. AMC physician Joost Wiersinga and the Laboratory for Experimental Internal Medicine discovered which gene-protein combination renders the lethal bacteria B. pseudomallei harmless.
Immune system fooled

Wiersinga focussed on the so-called Toll-like receptors. These are the proteins that initiate the fight against pathogens. There are currently ten known Toll-like receptors which are located on the outside of immune cells, our body's defence system. The toll-like receptors jointly function as a 10-figure alarm code. Upon coming into contact with the immune cell each bacterium enters its own Toll code. For known pathogens this sets off an alarm in the immune system and the defence mechanism is activated. Yet B. pseudomallei fools the system by entering the code of a harmless bacterium. As a result the body's defence system remains on standby.

Yet some people are resistant: they become infected but not ill. Wiersinga found a genetic cause for this resistance. He discovered which toll receptor can fend off B. pseudomallei. He did this by rearing mice DNA in which the gene for Toll2 production was switched on and off. 'The group where the gene for Toll2 was switched off, survived the bacterial infection', says Wiersinga. 'The other receptor that we investigated, Toll4, had no effect - even though for the past ten years medics had regarded this as the most important receptor.' The ultimate aim of this study is to develop a vaccine.

Wiersinga and his colleagues are working together with the Wellcome Trust in Oxford and a clinic in Thailand. B. pseudomallei is endemic in Asia and claims thousands of victims each year. The research was published in PloS Medicine, and Science and Nature Reviews also ran articles on it. NWO funded the work.

The Netherlands Organisation for Scientific Research (NWO)

Pseudomallei: Webster's Timeline History, 1876 - 2007
by Icon Group International (Author)

Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Pseudomallei," including when used in literature (e.g. all authors that might have Pseudomallei in their name). As such, this book represents the largest compilation of timeline events associated with Pseudomallei when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social...

Enhanced Biodegradation of Para-nitrophenol by Pseudomonas sp.: DegradationEfficacy of Pseudomonas pseudomallei and their Mutants on Paranitrophenol
by Saira Azam (Author), Zafar M Kahlid (Author), Abdul Qayyum Rao (Author)

Biodegradation of paranitrophenol (PNP) was carried out using Pseudomonas pseudomallei capable for PNP degradation. For enhanced biodegradation this strain was subjected to UV ray, chemical and gamma ray mutagenesis. UV and chemical mutagenesis was not fruitful as no PNP hyper degrading bacterial strain was obtained. Gamma ray mutagenesis was positive for PNP degradation and hyper degrading bacterial strain was obtained. Both parent and mutant in presence of glucose, efficiently degraded PNP. When concentration of glucose increased from 50 to 100 ppm then 50 ppm PNP was degraded within 12 hours by mutant and in 20 hours by parent. So glucose had positive effect on PNP degradation and resulted in enhanced PNP degradation. Effect of phenol was also checked on PNP degradation. The result...

Counter-selection markers for allele replacement in Burkholderia pseudomallei.
by Carolina Maria Lopez-Pelaez (Author)

Burkholderia pseudomallei is a gram negative bacillus that lives in the soil of tropical regions around the planet and causes melioidosis in humans, a disease endemic in regions of Southeast Asia and Northern Australia. The United States government has classified B. pseudomallei, and its relative Burkholderia mallei, as potential bioterrorism agents. The increased interest in these complex pathogens initiated a quest to better understand the biology of these bacteria at the molecular level. Completed genome sequences of diverse strains have provided a wealth of information that opened new venues for further study. Many genetic tools have been successfully adapted for use in Burkholderia species, but others are yet to be discovered. The ability to introduce unmarked single nucleotide...

Drug efflux systems and antibiotic resistance in Burkholderia pseudomallei.
by Lily Trunck (Author)

Burkholderia pseudomallei, the etiologic agent of melioidosis, is intrinsically resistant to most antibiotics. A predicted 10 RND efflux transporters are encoded by the B. pseudomallei genome; 3 have been characterized (AmrAB-OprA, BpeAB-OprB, and BpeEF-OprC) as major contributors to the intrinsic aminoglycoside, macrolide, chloramphenicol, and trimethoprim resistance of this organism. AmrAB-OprA is constitutively expressed in most strains and confers resistance to aminoglycosides. Gentamicin susceptible clinical isolates have been identified and work in this dissertation demonstrates that such susceptibility occurs as a result of either insufficient expression or deletion of amrAB-oprA. The mechanisms regulating expression in these strains are unclear, but are not related to mutations in...

Melioidosis in western Europe (Pseudomonas pseudomallei) =: Zum Vorkommen von Pseudorotz (Melioidose) in Westeuropa
by H Mayer (Author)

Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century (Emerging Infectious Diseases of the 21st Century)
by I.W. Fong (Editor), Kenneth Alibek (Editor)

Compiled by two leading experts in the field, this volume provides a concise, timely, and authoritative review of some of the most problematic infections of the new century. It presents issues and new ideas for preventing and controlling infectious diseases.

BSL3 and BSL4 Agents
by Mandy Elschner (Author), Sally Cutler (Author), Manfred Weidmann (Author), Patrick Butaye (Author)

In one handy book, this reference gathers all the necessary information on 14 of the most commonly used dangerous groups of pathogens in biosafety level 3 and 4 laboratories. All the chapters are uniformly structured, with a brief overview of the microbiology, pathology, epidemiology and detection methods for each group. In addition, a whole chapter is devoted to the special biosafety requirements, disinfection, decontamination protocols, accident literature and accident procedures, as well as treatment options for all the organisms. This chapter is clearly marked and easy to find when opening the book.
Essential literature for the increasing number of BSL3 or BSL4 labs worldwide and for medical facilities intervening in the case of an incident.

Machine Learning Approaches to Bioinformatics (Science, Engineering, and Biology Informatics)
by Zheng Rong Yang (Author)

This book covers a wide range of subjects in applying machine learning approaches for bioinformatics projects. The book succeeds on two key unique features. First, it introduces the most widely used machine learning approaches in bioinformatics and discusses, with evaluations from real case studies, how they are used in individual bioinformatics projects. Second, it introduces state-of-the-art bioinformatics research methods. The theoretical parts and the practical parts are well integrated for readers to follow the existing procedures in individual research. Unlike most of the bioinformatics books on the market, the content coverage is not limited to just one subject. A broad spectrum of relevant topics in bioinformatics including systematic data mining and computational systems biology...

Management of Multiple Drug-Resistant Infections (Infectious Disease)
by Stephen H. Gillespie (Editor)

A comprehensive and cutting-edge review of how practicing physicians can best treat multiple drug resistance in bacterial, viral, protozoal, and helminthic infections. The authors focus on the major hospital and community-acquired pathogens, including S. aureus, S. pneumoniae, Enterococcus, Acinetobacter, and M. tuberculosis, and on the management of such common problems as multiple drug-resistant urinary tract infections and gonorrhea. Among the resistant tropical organisms covered are Salmonella typhi, malaria, and Burkholderia pseudomalei. Resistance to such important antiviral classes as antiretrovirals and anticytomegalovirals is also discussed, as are those measures necessary to prevent the spread of infections patients.

Biological Weapons Defense: Infectious Disease and Counterbioterrorism (Infectious Disease)
by Luther E. Lindler (Editor), Frank J. Lebeda (Editor), George Korch (Editor)

Prominent experts in biodefense research-many from the US Army Medical Research Institute of Infectious Diseases-authoritatively delineate the universe of scientific, medical, and legal issues facing the biodefense research community. Regarding medical countermeasures and decontamination, the authors describe the treatment and pathogenesis of a variety of established pathogens (anthrax, plague, smallpox, Brucellosis, Glanders, and Coxiella burnettii) and review what is known about the aerosol route of infection and decontamination processes. They also examine how to discover the presence of these agents, or other previously unknown biological weapons, and detail the ongoing efforts to counter these agents, including proteomic and genomic analysis as a gateway to better diagnostics,...